Fluorescent probe for detecting hypochlorous acid as well as preparation method and application of fluorescent probe
By designing a structure-specific fluorescent probe, using the reaction of 4-(diethylamino)salicylate with dimethylaminothioformyl chloride, the problems of low sensitivity and poor selectivity of existing fluorescent probes are solved, and the problem of low sensitivity and poor selectivity of existing fluorescent probes is achieved. It has high sensitivity detection and selectivity for hypochlorous acid, and is suitable for hypochlorous acid detection in living cells and living organisms.
Patent Information
- Application Number
- CN202410974527.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-19
- Publication Date
- 2024-11-08
AI Technical Summary
Existing hypochlorous acid fluorescent probes have low sensitivity, poor selectivity and limited applications in vivo bioimaging, making it difficult to effectively detect hypochlorous acid in living cells and living organisms.
A structurally specific fluorescent probe was designed to synthesize intermediates by 4-(diethylamino)salicylate and dimethylaminothioformyl chloride under alkaline conditions, and condensate with malonitrile to form Fluorescent probes with high responsiveness to hypochlorous acid. When the probe encounters hypochlorous acid, it will undergo intramolecular cyclization, enhance the fluorescence intensity, and have a good linear relationship to hypochlorous acid concentration, with light stability and high Selective.
It realizes high sensitivity detection of hypochlorous acid, has good selectivity, is not disturbed by ROS, RNS, metal ions and amino acids, and is suitable for hypochlorous acid detection in living cells and living organisms. It has a simple synthesis method and is suitable for amplification. Synthesis and practical production applications.
Smart Images

Figure CN118908869A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biological detection technology, and in particular to a fluorescent probe for detecting hypochlorous acid, a preparation method and an application thereof. Background Art
[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] Hypochlorous acid is produced by C1 - Hypochlorous acid is an important reactive oxygen species produced by the action of myeloperoxidase in biological systems. Although hypochlorous acid is present in extremely low concentrations in biological systems, it plays a key role in immune defense. However, due to its high reactivity, excessive hypochlorous acid can cause a series of diseases closely related to inflammation. Therefore, it is of great significance to establish a satisfactory detection method for detecting natural hypochlorous acid in living cells and living bodies.
[0004] Compared with other traditional methods, small molecule fluorescent probes have outstanding sensitivity and high spatiotemporal resolution in bioimaging applications. In recent years, fluorescent probes of hypochlorous acid based on different recognition receptors have been designed. However, although these fluorescent probes have their unique advantages in many aspects, they still have the disadvantages of low sensitivity, poor selectivity and limited in vivo bioimaging applications. Summary of the invention
[0005] In order to overcome the above problems, the present invention provides a fluorescent probe for detecting hypochlorous acid, and a preparation method and application thereof.
[0006] In order to achieve the above technical objectives, the present invention adopts the following technical solutions:
[0007] In a first aspect of the present invention, a fluorescent probe is provided, the structural formula of which is shown in Formula I.
[0008]
[0009] The second aspect of the present invention provides a method for preparing the above fluorescent probe, comprising the following steps:
[0010] 4-(Diethylamino) salicylaldehyde reacts with dimethylaminothiocarbonyl chloride under alkaline conditions to undergo nucleophilic substitution to synthesize an intermediate; the intermediate reacts with malononitrile to undergo reverse condensation to synthesize a fluorescent probe;
[0011] Reaction route:
[0012]
[0013] In one or more embodiments, 4-(diethylamino) salicylaldehyde and dimethylaminothiocarbonyl chloride undergo nucleophilic substitution under alkaline conditions, and the method for synthesizing the intermediate includes:
[0014] 4-(Diethylamino) salicylaldehyde, dimethylaminothiocarbonyl chloride and cesium carbonate are dispersed in acetonitrile and heated to react under nitrogen protection to synthesize an intermediate.
[0015] Preferably, the molar ratio of 4-(diethylamino) salicylaldehyde, dimethylaminothiocarbonyl chloride and cesium carbonate is 1:2.8-3.2:4.5-6, preferably 1:3:5.
[0016] Preferably, the concentration of 4-(diethylamino)salicylaldehyde in acetonitrile is 0.24-0.26 mol / L, preferably 0.25 mol / L.
[0017] Preferably, the heating reaction temperature is 45 to 60° C., preferably 50° C.; the heating reaction time is 5 to 7 h, preferably 6 h.
[0018] In one or more embodiments, the intermediate reacts with malononitrile to form the fluorescent probe, which comprises: dispersing the intermediate and malononitrile in ethanol, adding piperidine as a catalyst, heating the reaction under nitrogen protection, and synthesizing the fluorescent probe.
[0019] Preferably, the molar ratio of the intermediate to malononitrile is 5 to 6:17, preferably 5.7:17.
[0020] Preferably, the concentration of the intermediate in ethanol is 0.25-0.3 mol / L, preferably 0.285 mol / L.
[0021] Preferably, the heating reaction temperature is 45 to 60° C., preferably 50° C.; the heating reaction time is 5 to 7 h, preferably 6 h.
[0022] The third aspect of the present invention provides use of the fluorescent probe described in the first aspect and / or the fluorescent probe prepared by the preparation method described in the second aspect in detecting hypochlorous acid.
[0023] The beneficial effects of the present invention are:
[0024] (1) In the present invention, 4-(diethylamino) salicylaldehyde is used as the parent, and dimethylaminothiocarbonyl chloride is connected as the recognition group to design a fluorescent probe that specifically responds to hypochlorous acid. Before the fluorescent probe responds to hypochlorous acid, the fluorescence intensity is weak due to the non-radiative transition of the excited state energy; when the fluorescent probe encounters hypochlorous acid, hypochlorous acid reacts with dimethylaminothiocarbonyl chloride to expose the hydroxyl group, and then intramolecular cyclization occurs, the rigid structure is greatly increased, and the intramolecular rotation is hindered, so that the fluorescence intensity is greatly enhanced, thereby achieving a fluorescent response to hypochlorous acid.
[0025] (2) The fluorescent probe provided by the present invention has a strong fluorescence response after reacting with hypochlorous acid, and there is a good linear relationship between it and the concentration of hypochlorous acid (0-9 μM), and the fluorescence response increases with the increase of the concentration of hypochlorous acid. At the same time, the fluorescent probe provided by the present invention has a strong selectivity for hypochlorous acid and is not interfered by ROS, regenerative nutrients (RNS), common metal ions and amino acids; furthermore, within 1 hour of laser irradiation, the fluorescence intensity remains almost unchanged, indicating that the probe has good photostability.
[0026] (3) The fluorescent probe provided by the present invention has a simple and convenient synthesis method, high yield, is easy to prepare, and is suitable for scaled-up synthesis and actual production applications. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0028] Figure 1 This is the H NMR spectrum of the intermediate;
[0029] Figure 2 The NMR carbon spectrum of the intermediate;
[0030] Figure 3 High-resolution mass spectrometry of intermediates;
[0031] Figure 4 It is the H NMR spectrum of the fluorescent probe;
[0032] Figure 5 The NMR carbon spectrum is a fluorescent probe;
[0033] Figure 6 High-resolution mass spectrometry for fluorescent probes;
[0034] Figure 7 a is the fluorescence spectrum of the fluorescent probe after responding to different concentrations of hypochlorous acid; b is the linear range of the fluorescent probe responding to hypochlorous acid;
[0035] Figure 8 The selectivity of the fluorescent probe to hypochlorous acid;
[0036] Fig. 9 The photostability of the fluorescent probe before and after responding to hypochlorous acid;
[0037] Fig.10 a is the fluorescence imaging of the fluorescent probe before myoblasts were treated with LPS, b is the fluorescence imaging of the fluorescent probe after myoblasts were treated with LPS, and c is the fluorescence imaging of the fluorescent probe after myoblasts were treated with NAC after LPS stimulation; d is the specific fluorescence intensity value in a, b and c;
[0038] Fig.11 Figure a is the fluorescence imaging of the fluorescent probe in the control group of mouse hind leg muscles; Figure b is the fluorescence imaging of the fluorescent probe in the mouse hind leg muscles after LPS treatment; Figure c is the specific fluorescence intensity value in Figures a and b;
[0039] Fig.12 In the figure, a is the fluorescence imaging of the fluorescent probe in healthy human muscle tissue; b is the fluorescence imaging of the fluorescent probe in inflammatory tissue; c is the specific fluorescence intensity value in figures a and b; d is the pathological section of the infected tissue. DETAILED DESCRIPTION
[0040] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used in the present invention have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0041] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprising" and / or "including" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.
[0042] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below in conjunction with specific embodiments.
[0043] Example 1
[0044] Fluorescent probe preparation:
[0045] 0.97 g of 4-(diethylamino) salicylaldehyde, 1.85 g of dimethylaminothiocarbonyl chloride, and 8.14 g of cesium carbonate were dissolved in 20 mL of acetonitrile solution, reacted at 50° C. for 6 h under nitrogen protection, and separated by column chromatography to obtain a yellow intermediate.
[0046] Take 1.6 g of the intermediate, 1.13 g of malononitrile, and 938 μL of piperidine, dissolve them in 20 mL of ethanol, react at 50 °C for 4 h under nitrogen protection, and separate by column chromatography to obtain the fluorescent probe;
[0047] Reaction route:
[0048]
[0049] The H-NMR spectrum, C-NMR spectrum and high-resolution mass spectrum of the intermediate are shown in Figures 1 to 3 shown.
[0050] 1 H NMR (400MHz, CDCl3): δ9.72 (s, 1H), δ7.69 (d, J = 12Hz, 1H), δ6.56-6.54 (m, 1H), δ6.24(d,1H), δ3.45(t,J=8Hz,4H), δ3.38(t,J=4Hz,6H), δ1.19(t,J=8Hz,6H).
[0051] 13 C NMR (100MHz): δ186.22,185.33,156.33,151.83,131.14,116.14,107.73,104.82,52.49,43.87,42.30,37.92,28.68,11.57.
[0052] HRMS(ESI),m / z calcd for C 14 H 20 N2O2S[M+H] + 281.1318, found 281.1330.
[0053] The H-NMR spectrum, C-NMR spectrum and high-resolution mass spectrum of the fluorescent probe are shown in Figure 2. Figures 4 to 6 shown.
[0054] 1 H NMR (400MHz, CDCl3): δ8.35 (s, 1H), δ7.51 (d, J = 8Hz, 1H), δ6.67-6.64 (m, 1H), δ6.32 (d, 1H), δ3.45-3.40 (m, 6H), δ1.24 (t, J = 12Hz, 6H), δ0.06 (s, 3H).
[0055] 13 C NMR(100MHz):185.32,155.42,151.86,149.93,129.07,115.21,113.76,112.13,109.36,105.60,71.69,44.43,42.52,33.08,11.59.
[0056] HRMS(ESI),m / z calcd for C 17 H 20 N4OS[M+Na] + 351.1250, found 351.1272.
[0057] Example 2
[0058] In this example, the fluorescence performance of the fluorescent probe prepared in Example 1 was evaluated.
[0059] The fluorescent probe prepared in Example 1 was dissolved in dimethyl sulfoxide (DMSO) to prepare a 1 mM probe stock solution, which was diluted with PBS to a 5 μM sample solution. The effect of different concentrations of hypochlorous acid (0 to 9 μM) on the fluorescence spectrum of the probe was tested. Specifically, in the PBS solution, the fluorescent probe (5 μM) reacted with hypochlorous acid for 1 min and then the fluorescence test was performed. The results are as follows: Figure 7 As shown, from Figure 7 As can be seen in a, the excitation wavelength of the fluorescent probe is 430nm, and the emission wavelength is 480nm. As the concentration of hypochlorous acid increases, the fluorescence intensity increases; and there is a good linear relationship between the fluorescence intensity of the fluorescent probe and the concentration of hypochlorous acid (0-9μM), as shown in Figure 7 As shown in b.
[0060] Specificity test:
[0061] In PBS solution, the fluorescent probe (5 μM) was reacted with different ROS (O2 ·- 、H2O2、·OH、 1 O2)、RNS(NO·、ONOO - ), common metal ions (K + Mg 2+ 、Zn 2+ 、Na + , Cu 2+ , Fe 3+ , Ca 2+ , Mn 2+ and Fe 2+ ) and amino acids (Gly, Glu, Arg, Ala, His, Cys and Tyr) were reacted for 1 min and then fluorescence test was performed. Figure 8 As shown, the results show that the fluorescent probe provided by the present invention has strong selectivity for hypochlorous acid and is not interfered by ROS, RNS, common metal ions and amino acids.
[0062] Photostability test: In PBS solution, the fluorescent probe (5 μM) was tested for fluorescence in the presence or absence of hypochlorous acid. The results are as follows: Fig. 9 As shown, the fluorescence intensity remained almost unchanged within 1 h of laser irradiation, indicating that the probe has good photostability.
[0063] Experimental Example 1
[0064] 3.1 Imaging HClO in cells:
[0065] Use 3 μg mL -1Myoblasts were treated with lipopolysaccharide (LPS) for 12 h and then incubated with 40 μM probe for 60 min before imaging. Cells stimulated with LPS showed stronger fluorescence intensity than untreated cells ( Fig.10 After LPS stimulation, myoblasts were incubated with N-acetylcysteine (NAC) for 60 min, and then the cells were incubated with the probe and imaged. It was observed that the intracellular fluorescence intensity was significantly reduced ( Fig.10 (c), indicating that the probe can be used to detect changes in intracellular hypochlorous acid levels.
[0066] 3.2 Imaging Hypochlorous Acid in Mouse Tissue Sections:
[0067] The mice were injected intramuscularly with 100 μL of LPS (2 mg mL -1 ) An acute inflammatory mouse model was constructed. The control group was injected with an equal amount of PBS, which induced local acute inflammation 6 hours later. The mice were killed by dislocation of the neck, and muscle tissue sections were incubated with 40 μM probe for imaging. Compared with the PBS group, the fluorescence intensity of LPS-treated muscle tissue was significantly increased ( Fig.11 (a and b) show that the probe can detect changes in HClO levels in mouse leg muscle tissue.
[0068] 3.3 Imaging HClO in human muscle tissue sections:
[0069] After slicing healthy muscle tissue and inflammatory tissue, the probe was incubated with 40μM probe for imaging. It can be seen that the probe has a lower fluorescence intensity in healthy tissue, and the fluorescence intensity is significantly increased in inflammatory tissue ( Fig.12 (a and b) show that the probe can distinguish healthy and inflammatory tissues through the difference in HClO levels between healthy and inflammatory tissues.
[0070] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A fluorescent probe, characterized in that The structural formula is shown in Formula Ⅰ.
2. The method for preparing the fluorescent probe according to claim 1, characterized in that: The following steps are involved: 4-(Diethylamino) salicylaldehyde reacts with dimethylaminothiocarbonyl chloride under alkaline conditions to undergo nucleophilic substitution to synthesize an intermediate; the intermediate reacts with malononitrile to undergo reverse condensation to synthesize a fluorescent probe; Reaction route:
3. The preparation method according to claim 2, characterized in that: 4-(Diethylamino) salicylaldehyde and dimethylaminothiocarbonyl chloride undergo nucleophilic substitution under alkaline conditions, and the method for synthesizing the intermediate includes: 4-(Diethylamino) salicylaldehyde, dimethylaminothiocarbonyl chloride and cesium carbonate are dispersed in acetonitrile and heated to react under nitrogen protection to synthesize an intermediate.
4. The preparation method according to claim 3, characterized in that: The molar ratio of 4-(diethylamino) salicylaldehyde, dimethylaminothiocarbonyl chloride and cesium carbonate is 1:2.8-3.2:4.5-6, preferably 1:3:5; Alternatively, the concentration of 4-(diethylamino)salicylaldehyde in acetonitrile is 0.24 to 0.26 mol / L, preferably 0.25 mol / L.
5. The preparation method according to claim 3, characterized in that: The temperature of the heating reaction is 45 to 60° C., preferably 50° C.; the time of the heating reaction is 5 to 7 hours, preferably 6 hours.
6. The preparation method according to claim 2, characterized in that: The intermediate reacts with malononitrile to produce condensation, and the method for synthesizing the fluorescent probe comprises: dispersing the intermediate and malononitrile in ethanol, adding piperidine as a catalyst, heating the reaction under nitrogen protection, and synthesizing the fluorescent probe.
7. The preparation method according to claim 6, characterized in that: The molar ratio of the intermediate to malononitrile is 5 to 6:17, preferably 5.7:
17.
8. The preparation method according to claim 6, characterized in that: The concentration of the intermediate in ethanol is 0.25 to 0.3 mol / L, preferably 0.285 mol / L.
9. The preparation method according to claim 6, characterized in that: The temperature of the heating reaction is 45 to 60° C., preferably 50° C.; the time of the heating reaction is 5 to 7 hours, preferably 6 hours.
10. Use of the fluorescent probe according to claim 1 and / or the fluorescent probe prepared by the preparation method according to any one of claims 2 to 9 in detecting hypochlorous acid.
